NIAID
NIH Awards $2.4M to Improve Syphilis Diagnostics
The 10 awards cover different novel diagnostic approaches as well as biomarker discovery and pre-analytical methods.
Day Zero Diagnostics Wins $300K SBIR Grant for Fecal Microbiota Transplant Assay
The Boston firm will develop a sequencing-based safety and efficacy assay for fecal microbiota transplants called epiXact FMT.
Phase Genomics Wins $5.5M in NIH, Gates Foundation Grants for Therapeutic Phage Discovery
The company will use its proximity-guided metagenomics platform to build an atlas of phage-bacteria interactions and identify phages that could be used therapeutically.
UCSF-led Team Wins $112M NIH Grant to Harness Omics Tools for Antiviral Target, Drug Development
Premium
The researchers will use a variety of omics tools, including a protein-protein interaction workflow they previously employed to look for drugs against SARS-CoV-2.
Sequencing Leads to Diagnoses in Significant Subset of Immune Conditions in NIAID Program
In the first 1,000 families tested through a sequencing-based program at the National Institute of Allergy and Infectious Diseases, researchers diagnosed almost a third of cases.